Question 1

What is PT-141?

Accepted Answer

PT-141 (Bremelanotide) is a synthetic cyclic heptapeptide melanocortin receptor agonist, derived from Melanotan II. It is produced for controlled preclinical research applications.

Question 2

What research models use PT-141?

Accepted Answer

PT-141 is examined in preclinical models studying melanocortin-3 and melanocortin-4 receptor signaling, peptide-receptor binding dynamics, and cyclic peptide structure-activity relationships.

Question 3

How is product quality verified?

Accepted Answer

Every batch undergoes 7 rounds of independent analytical testing including HPLC purity analysis, mass spectrometry identity confirmation, endotoxin screening, and sterility verification. Full Certificates of Analysis documenting all results are available for each production lot.

Question 4

Can this compound be studied alongside other research peptides?

Accepted Answer

In controlled laboratory settings, researchers may evaluate this compound in combination with other peptides to examine complementary or overlapping signaling pathways within established research protocols.

SKU	IP-PT141-10
Intended Use	For laboratory research use only. Not for human consumption.